elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37742014-2FEBB06D-9C5F-480A-8135-8A70ADC26861
Q37742014-2FEBB06D-9C5F-480A-8135-8A70ADC26861
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37742014-2FEBB06D-9C5F-480A-8135-8A70ADC26861
Targeted therapy for soft tissue sarcomas in adolescents and young adults.
P2860
Q37742014-2FEBB06D-9C5F-480A-8135-8A70ADC26861
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37742014-2FEBB06D-9C5F-480A-8135-8A70ADC26861
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
613e4378adf06c60233e1b19efc0782dd56c721c
P2860
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.